FAM167B

gene
On this page

Also known as MGC10820DIORA-2

Summary

FAM167B (family with sequence similarity 167 member B, HGNC:28133) is a protein-coding gene on chromosome 1p35.2, encoding Protein FAM167B (Q9BTA0).

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 24 total
  • MANE Select transcript: NM_032648

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28133
Approved symbolFAM167B
Namefamily with sequence similarity 167 member B
Location1p35.2
Locus typegene with protein product
StatusApproved
AliasesMGC10820, DIORA-2
Ensembl geneENSG00000183615
Ensembl biotypeprotein_coding
Entrez84734

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000373582, ENST00000857788

RefSeq mRNA: 1 — MANE Select: NM_032648 NM_032648

CCDS: CCDS358

Canonical transcript exons

ENST00000373582 — 2 exons

ExonStartEnd
ENSE000016503913224722232247682
ENSE000017432793224837132248856

Expression profiles

Bgee: expression breadth ubiquitous, 162 present calls, max score 89.81.

FANTOM5 (CAGE): breadth broad, TPM avg 2.0095 / max 131.8246, expressed in 533 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
19661.7233505
19670.124852
19690.084127
19680.077425

Top tissues by expression

247 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
kidney epitheliumUBERON:000481989.81gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047388.56gold quality
apex of heartUBERON:000209887.70gold quality
right lobe of thyroid glandUBERON:000111986.23gold quality
metanephros cortexUBERON:001053385.92gold quality
left ventricle myocardiumUBERON:000656685.56gold quality
right adrenal glandUBERON:000123385.11gold quality
right adrenal gland cortexUBERON:003582784.45gold quality
mucosa of transverse colonUBERON:000499184.35gold quality
left adrenal glandUBERON:000123483.98gold quality
left adrenal gland cortexUBERON:003582583.94gold quality
adenohypophysisUBERON:000219683.87gold quality
adrenal cortexUBERON:000123583.81gold quality
pituitary glandUBERON:000000783.69gold quality
cardiac muscle of right atriumUBERON:000337983.65gold quality
left lobe of thyroid glandUBERON:000112082.96gold quality
upper lobe of left lungUBERON:000895282.50gold quality
upper arm skinUBERON:000426382.46gold quality
thyroid glandUBERON:000204682.14gold quality
upper lobe of lungUBERON:000894882.07gold quality
omental fat padUBERON:001041482.04gold quality
peritoneumUBERON:000235882.01gold quality
adult mammalian kidneyUBERON:000008281.96gold quality
endocervixUBERON:000045881.46gold quality
body of uterusUBERON:000985381.42gold quality
myometriumUBERON:000129681.10gold quality
adrenal glandUBERON:000236981.08gold quality
metanephrosUBERON:000008181.03gold quality
adipose tissue of abdominal regionUBERON:000780880.65gold quality
pericardiumUBERON:000240779.44silver quality

Single-cell (SCXA)

Detected in 9 experiment(s), a significant marker in 8.

ExperimentMarker?Max mean expression
E-HCAD-1yes46.01
E-MTAB-10553yes45.80
E-HCAD-11yes45.45
E-HCAD-10yes36.38
E-MTAB-6701yes29.29
E-MTAB-8410yes20.59
E-HCAD-9yes11.81
E-ANND-3yes5.44
E-MTAB-6678no2.43

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

14 targeting FAM167B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5193100.0067.261744
HSA-MIR-50799.9770.111915
HSA-MIR-55799.9670.011640
HSA-MIR-4731-5P99.8967.232537
HSA-MIR-877-3P99.0968.101637
HSA-MIR-6749-3P99.0065.731443
HSA-MIR-2467-3P98.6567.181969
HSA-MIR-6804-5P98.3965.771084
HSA-MIR-770397.6467.00965
HSA-MIR-468996.9765.791209
HSA-MIR-1292-5P96.7462.14238
HSA-MIR-6858-5P96.0564.591020
HSA-MIR-447195.1166.84755
HSA-MIR-805995.1166.30646

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriofam167bENSDARG00000100426
mus_musculusFam167bENSMUSG00000050493
rattus_norvegicusFam167bENSRNOG00000049425

Paralogs (3): FAM167A (ENSG00000154319), AARD (ENSG00000205002), C20orf202 (ENSG00000215595)

Protein

Protein identifiers

Protein FAM167BQ9BTA0 (reviewed: Q9BTA0)

All UniProt accessions (1): Q9BTA0

UniProt curated annotations — full annotation on UniProt →

Similarity. Belongs to the FAM167 (SEC) family.

RefSeq proteins (1): NP_116037* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR024280FAM167Family
IPR051771FAM167_domainFamily

Pfam: PF11652

UniProt features (2 total): chain 1, coiled-coil region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BTA0-F176.850.29

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 49 (showing top): MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, chr1p35, HORIUCHI_WTAP_TARGETS_UP, NFE2L2.V2, SUPT16H_TARGET_GENES, TFEB_TARGET_GENES, GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP, MIR5193, GSE11924_TH2_VS_TH17_CD4_TCELL_UP, MIR7703, MIR4689, MIR6858_5P, GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_UP, GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP, GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_DN

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (0):

Protein interactions and networks

STRING

184 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
FAM167BFAM124AQ86V42566
FAM167BFHIP2AQ5W0V3560
FAM167BCYTL1Q9NRR1518
FAM167BFCRL6Q6DN72481
FAM167BFAM124BQ9H5Z6437
FAM167BSTK33Q9BYT3430
FAM167BEHD3Q9NZN3411
FAM167BSLC35H1Q9NQQ7374
FAM167BWDR86Q86TI4370
FAM167BDTD2Q96FN9352
FAM167BFHIP2BQ86V87336
FAM167BZFYVE19Q96K21324
FAM167BPNMA8AQ86V59323
FAM167BFAM184AQ8NB25323
FAM167BLRRC14Q15048307

IntAct

113 interactions, top by confidence:

ABTypeScore
FAM167BLNX2psi-mi:“MI:0407”(direct interaction)0.440
FAM167BMAGI1psi-mi:“MI:0407”(direct interaction)0.440
FAM167BMAST2psi-mi:“MI:0407”(direct interaction)0.440
MAGI2FAM167Bpsi-mi:“MI:0407”(direct interaction)0.440
FAM167BTJP2psi-mi:“MI:0407”(direct interaction)0.440
FAM167BMAGI3psi-mi:“MI:0407”(direct interaction)0.440
LNX1FAM167Bpsi-mi:“MI:0407”(direct interaction)0.440
FAM167BRADILpsi-mi:“MI:0407”(direct interaction)0.440
FAM167BHTRA4psi-mi:“MI:0407”(direct interaction)0.440
FAM167BHTRA3psi-mi:“MI:0407”(direct interaction)0.440
FAM167BHTRA1psi-mi:“MI:0407”(direct interaction)0.440
FAM167BHTRA2psi-mi:“MI:0407”(direct interaction)0.440
FAM167BDLG2psi-mi:“MI:0407”(direct interaction)0.440
FAM167BDLG3psi-mi:“MI:0407”(direct interaction)0.440
FAM167BDLG4psi-mi:“MI:0407”(direct interaction)0.440
FAM167BTAMALINpsi-mi:“MI:0407”(direct interaction)0.440
FAM167BDLG1psi-mi:“MI:0407”(direct interaction)0.440
FAM167BNHERF4psi-mi:“MI:0407”(direct interaction)0.440
FAM167BMAGI2psi-mi:“MI:0407”(direct interaction)0.440
FAM167BGRID2IPpsi-mi:“MI:0407”(direct interaction)0.440
FAM167BARHGEF12psi-mi:“MI:0407”(direct interaction)0.440
FAM167BPDZK1psi-mi:“MI:0407”(direct interaction)0.440
FRMPD2FAM167Bpsi-mi:“MI:0407”(direct interaction)0.440
FAM167BLIN7Bpsi-mi:“MI:0407”(direct interaction)0.440
FAM167BWHRNpsi-mi:“MI:0407”(direct interaction)0.440

ESM2 similar proteins: A1L168, A1L3T7, A6NGS2, A6QQF7, D4A8G3, O15049, P0C7N2, P0C7N4, P17257, P58660, Q08AY9, Q0V7M8, Q0VDN7, Q14BJ1, Q2NL23, Q3KP66, Q3LUD3, Q3UNU4, Q4LEZ3, Q566R4, Q571B6, Q5BJW5, Q5ND29, Q5RFZ7, Q5XIS1, Q6NSJ2, Q6P1G6, Q6Q0N2, Q7TN12, Q7TSI1, Q811W1, Q8BL43, Q8C7U1, Q8IV03, Q8K1S6, Q8K2P1, Q8N137, Q8N5H3, Q8TE77, Q8WWL2

Diamond homologs: P17257, Q0V7M8, Q5RFZ7, Q6P1G6, Q96KS9, Q9BTA0

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 73 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Ras activation upon Ca2+ influx through NMDA receptor559.5×7e-07
Unblocking of NMDA receptors, glutamate binding and activation556.6×7e-07
Negative regulation of NMDA receptor-mediated neuronal transmission556.6×7e-07
Assembly and cell surface presentation of NMDA receptors1052.9×2e-13
Dopamine Neurotransmitter Release Cycle551.7×1e-06
Long-term potentiation549.6×1e-06
Neurexins and neuroligins1145.1×8e-14
Protein-protein interactions at synapses738.7×3e-08

GO biological processes:

GO termPartnersFoldFDR
establishment or maintenance of epithelial cell apical/basal polarity1191.3×4e-17
protein localization to synapse665.7×3e-08
receptor clustering762.4×3e-09
regulation of postsynaptic membrane neurotransmitter receptor levels749.6×1e-08
protein-containing complex assembly914.6×6e-07
cell-cell adhesion1014.5×1e-07
protein localization to plasma membrane57.8×7e-03
chemical synaptic transmission77.7×8e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

24 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance23
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

170 predictions. Top by Δscore:

VariantEffectΔscore
1:32247679:GCTG:Gdonor_gain0.9900
1:32247681:TGGTG:Tdonor_loss0.9900
1:32247683:GTG:Gdonor_loss0.9900
1:32247684:T:Gdonor_loss0.9900
1:32248369:A:AGacceptor_gain0.9900
1:32248369:AGCG:Aacceptor_gain0.9900
1:32248370:G:GGacceptor_gain0.9900
1:32248370:GCGG:Gacceptor_gain0.9900
1:32247683:G:GGdonor_gain0.9800
1:32248369:AGC:Aacceptor_gain0.9800
1:32248370:GC:Gacceptor_gain0.9800
1:32248370:GCG:Gacceptor_gain0.9800
1:32247685:GA:Gdonor_loss0.9700
1:32248369:AGCGG:Aacceptor_gain0.9600
1:32248370:GCGGG:Gacceptor_gain0.9600
1:32248372:G:Aacceptor_gain0.9600
1:32248366:C:Aacceptor_gain0.9500
1:32248366:CGCA:Cacceptor_loss0.9400
1:32248367:GCA:Gacceptor_loss0.9400
1:32248368:CA:Cacceptor_loss0.9400
1:32248369:AG:Aacceptor_loss0.9400
1:32248370:G:Aacceptor_loss0.9400
1:32248371:CGGG:Cacceptor_gain0.9400
1:32247570:TCCA:Tdonor_gain0.9100
1:32248371:C:CAacceptor_gain0.9100
1:32247680:CTG:Cdonor_gain0.9000
1:32247681:TG:Tdonor_gain0.9000
1:32247682:GG:Gdonor_gain0.9000
1:32248364:GCCGC:Gacceptor_loss0.9000
1:32248362:C:Aacceptor_gain0.8800

AlphaMissense

1026 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:32248587:T:CF160L0.976
1:32248589:C:AF160L0.976
1:32248589:C:GF160L0.976
1:32247638:T:CF73L0.956
1:32247640:C:AF73L0.956
1:32247640:C:GF73L0.956
1:32247559:G:CW46C0.943
1:32247559:G:TW46C0.943
1:32248571:C:AN154K0.942
1:32248571:C:GN154K0.942
1:32248588:T:CF160S0.940
1:32247557:T:AW46R0.925
1:32247557:T:CW46R0.925
1:32247505:G:CK28N0.920
1:32247505:G:TK28N0.920
1:32248573:T:CI155T0.906
1:32248568:G:AM153I0.899
1:32248568:G:CM153I0.899
1:32248568:G:TM153I0.899
1:32248570:A:TN154I0.897
1:32248445:G:CK112N0.887
1:32248445:G:TK112N0.887
1:32248573:T:AI155N0.878
1:32248567:T:CM153T0.874
1:32248569:A:GN154D0.874
1:32248588:T:GF160C0.874
1:32247681:T:CL87P0.873
1:32248573:T:GI155S0.872
1:32247669:T:CL83P0.870
1:32248411:T:CL101P0.854

dbSNP variants (sampled 300 via entrez): RS1000352411 (1:32245943 TTTATTTAC>T,TTTATTTACTTATTTAC), RS1000383488 (1:32246330 C>T), RS1001098526 (1:32246701 A>G), RS1001352826 (1:32247270 C>T), RS1001462083 (1:32248305 A>G), RS1001530140 (1:32247032 C>G), RS1001831129 (1:32248035 G>T), RS1003686192 (1:32248660 C>A), RS1003718715 (1:32248885 G>C), RS1003861704 (1:32245668 A>C), RS1004904125 (1:32245264 G>T), RS1005943286 (1:32249152 C>A,T), RS1006019147 (1:32247710 C>A), RS1006622281 (1:32246927 G>A,T), RS1007167340 (1:32248284 G>A)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST009597_83Multiple sclerosis7.000000e-07

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

9 total (human), top 9 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
sulforaphanedecreases expression1
sodium arseniteaffects methylation1
butyraldehydedecreases expression1
Resveratrolaffects cotreatment, decreases expression1
Benzo(a)pyreneincreases methylation1
Dichlorodiphenyl Dichloroethylenedecreases expression1
Methotrexatedecreases expression1
Plant Extractsdecreases expression, affects cotreatment1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.